News Channels

10 Oct 2020 Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed with TP-1454 in Patients with Advanced Solid Tumors
10 Oct 2020 PENELOPE-B Trial of IBRANCE® (palbociclib) in Early Breast Cancer Did Not Meet Primary Endpoint
10 Oct 2020 Sobi announces topline phase 3 data of avatrombopag for the treatment of Chemotherapy-Induced Thrombocytopenia
10 Oct 2020 COVID-19 Long-Acting AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials
09 Oct 2020 Exelixis to Present the Preclinical Profile and Initial Clinical Pharmacokinetics of XL092, Its Next-Generation Oral Tyrosine Kinase Inhibitor
09 Oct 2020 Exelixis and Aurigene Announce That Promising Preclinical Data to Be Presented at the ENA Symposium Support the Clinical Development of a Novel CDK7 Inhibitor
09 Oct 2020 Selecta Biosciences and IGAN Biosciences Enter into Research License and Option Agreement to Study Selecta’s ImmTOR™ Immune Tolerance Platform in Combination with IGAN’s IgA Protease for the Treatment of IgA Nephropathy
09 Oct 2020 First Patient Enrolled in NIH Phase 3 Trial to Evaluate Potential COVID-19 Hyperimmune Medicine
09 Oct 2020 Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19 Patients Requiring Oxygen
08 Oct 2020 Cytovia Therapeutics partners with Inserm to develop selective CD38 NK therapeutics and offer new treatment options for Multiple Myeloma patients
08 Oct 2020 Vincera Pharma, Inc Announces Exclusive License Agreement for Oncology Portfolio Including a Clinical-stage PTEFb/CDK9 Inhibitor and a Preclinical Bioconjugation Platform
08 Oct 2020 Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure
08 Oct 2020 Almirall and the University of Dundee announce a multi-target research collaboration to develop novel Targeted Protein Degraders medicines
08 Oct 2020 TIO Bioventures Launches TCRyption Inc., a Novel TCR-T cell based Immunotherapy Company
08 Oct 2020 Ocular Therapeutix™ Announces Topline Phase 1 Clinical Trial Results of OTX-CSI
08 Oct 2020 Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency
08 Oct 2020 Moderna Announces Updates on Respiratory Syncytial Virus (RSV) Vaccine Program
08 Oct 2020 IMV Provides Updates On COVID-19 Vaccine Program
08 Oct 2020 Treatment With Islatravir and Doravirine Maintained Viral Suppression and No Viral Resistance was Identified
08 Oct 2020 Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up